NICE guidance | NICE Find guidance, advice and information for health, public health and social care professionals
ACC AHA Issue Updated Guideline for Managing Lipids, Cholesterol . . . Embargoed until 1 p m CT 2 p m ET, Friday, March 13, 2026 WASHINGTON and DALLAS, March 13, 2026 — The American College of Cardiology (ACC), the American Heart Association and nine other leading medical associations, today issued an updated guideline for the management of dyslipidemia—abnormal levels of one or more types of lipids or lipoproteins in the blood, including cholesterol and
WHO Guidelines Recommendations are statements designed to help end-users make informed decisions on whether, when and how to undertake specific actions such as clinical interventions, diagnostic tests or public health measures, with the aim of achieving the best possible individual or collective health outcomes
Clinical Guidelines | AHA ASA Journals The American Heart Association and American Stroke Association publish medical guidelines and scientific statements on various cardiovascular disease and stroke topics
Guideline - Affordable 401 (k)s for Companies Self-Employed Get all the tools you need to take care of your people and your business, all in one place Gusto customer? Get started With Gusto and Guideline together, your 401 (k) experience is seamlessly synced No error-prone third party integrations here Not a Gusto payroll customer? Not a problem
ICH Guidelines Harmonisation achievements in the Quality area include pivotal milestones such as the conduct of stability studies, defining relevant thresholds for impurities testing and a more flexible approach to pharmaceutical quality based on Good Manufacturing Practice (GMP) risk management
The American Diabetes Association Releases “Standards of Care in . . . Today, the American Diabetes Association® (ADA) released the “Standards of Care in Diabetes—2026” (Standards of Care), the gold standard in evidence-based guidelines for diagnosing and managing diabetes and prediabetes
E6 (R3) Good Clinical Practice (GCP) | FDA The Food and Drug Administration is announcing the availability of a final guidance for industry entitled “E6(R3) Good Clinical Practice ” This revision incorporates flexible, risk-based